Abstract:Background: Hepatitis B virus (HBV) infection is considered as an independent risk factor for poor prognosis in hepatocellular carcinoma (HCC) patients, but the molecular mechanisms have not been fully elucidated. Ectonucleotide pyrophosphatase-phosphodiesterase 2 (ENPP2) hydrolyzes lysophosphatidylcholine (LPC) to produce lysophosphatidic acid (LPA) and participates in virus replication and tumor progress. This study aimed to elucidate whether HBV infection inducing HCC progression via LPC/ENPP2/LPA axis. Methods: The clinical data for HCC patients were collected and prognosis was analyzed. The in vitro and in vivo experiments were used to investigate the influences of HBV, ENPP2 and activated hepatic stellate cell (HSC) on HCC progression. Findings: We found that ENPP2 expression was positively related to HBV infection and poor prognosis. HBV-induced HCC progression via ENPP2 was enhanced by LPC which was secreted by activated HSC. HCC patients with high ENPP2 combined with cirrhosis had worse prognosis than non-cirrhotic patients. In cirrhotic HCC patients, high ENPP2 expression cohort also had worse prognosis than low expression cohort. Interpretation: In HBV positive cirrhotic HCC patients, HBV enhanced host cell secretion of ENPP2, combined with LPC secreted by fibroblast to promote tumor progression via LPC/ENPP2/LPA. These findings may provide insights into novel approaches to HBV associated HCC therapy. Funding Statement: This study was supported by the National Natural Science Foundation of China (81801999, 81772597, 81672412, 81972255), the Guangdong Science and Technology Foundation (2017A030311002), the Science Foundation of Jiangxi (20181BAB214002), the Education Department Science and Technology Foundation of Jiangxi (GJJ170936) and grant from Guangdong Science and Technology Department (2017B030314026). Declaration of Interests: The authors declare no conflict of interest. Ethics Approval Statement: The clinicopathologic information of HCC patient (n = 774) and tumor tissues (n = 158) were obtained from Sun Yat-sen Memorial Hospital after approval by the hospital Ethical Committee. Animal studies were carried out in the South China University of Technology and approved by the Laboratory Animal Welfare and Ethics Committee of the South China University of Technology. All animal experiments conformed to the approved guidelines of Animal Care and Use Committee of South China University of Technology.

Study of HBV infection and hepatic progenitor cell activation in end-stage liver disease

Hbv Infection Involving in Hepatic Progenitor Cells Expansion in Hbv-Infected End-Stage Liver Disease

Characteristics of hepatic progenitor cells activation in liver tissues of patients with hepatitis B cirrhosis

Cellular Immune Response In Patients With Chronic Hepatitis B Virus Infection

Analysis of Epithelial-Mesenchymal Transition Markers in the Histogenesis of Hepatic Progenitor Cell in HBV-related Liver Diseases.

Immunohistochemical Study of Ductular Proliferation in Patients with Hepatitis B Virus Induced End-Stage Chronic Liver Disease

Expression of Platelet-Derived Growth Factor-Bb in Liver Tissues of Patients with Chronic Hepatitis B.

Stem-Like Cells In Hepatitis B Virus-Associated Cirrhotic Livers And Adjacent Tissue To Hepatocellular Carcinomas Possess The Capacity Of Tumorigenicity

The Relationship among Histopathological Indexes and Prognosis in Patients with Chronic Hepatitis B Infection

Ductular Proliferation in Liver Tissues with Severe Chronic Hepatitis B： an Immunohistochemical Study

Hepatitis B Virus Infection Promotes Hepatocellular Carcinoma Progression Through LPC/ENPP2/LPA Axis

The characteristic expression of B7-H3 and B7-H4 in liver biopsies from patients with HBV-related acute-on-chronic liver failure.

The expressions of PD-1 and PD-L1 and the correlation with the degree of liver damage in HBV chronic infection

Intrahepatic Expression of Programmed Death-1 and its Ligands in Patients with HBV-Related Acute-on-Chronic Liver Failure

Differential Proteome Analysis Of Hepatitis B Virus-Related Hepatocellular Carcinoma With And Without Cirrhosis From Formalin-Fixed And Paraffin-Embedded Tissue Samples

Intrahepatic levels of PD-1/PD-L correlate with liver inflammation in chronic hepatitis B

Programmed Death 1 and Programmed Death Ligand 1 Expressions in Patients with Chronic Hepatitis B

Immune Response Involved in Liver Damage and the Activation of Hepatic Progenitor Cells During Liver Tumorigenesis

The Study on the Characters of HBV-specific T Cells and Liver Damage Between HBeAg(+) and HBeAg(−) CHB Patients

Single-cell landscape of immune cells during the progression from HBV infection to HBV cirrhosis and HBV-associated hepatocellular carcinoma

Background Progenitor Activation is Associated with Recurrence after Hepatectomy of Combined Hepatocellular-Cholangiocarcinoma